ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'

NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy

Cambrex completes US$38 million capacity expansion in High Point, North Carolina

USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana

The delegation's visit covered a wide range of topics

Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform

The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades

Takara Bio Europe launches high-quality enzymes suitable for pre-clinical mRNA vaccine

Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection

The inspection has concluded successfully on 1st September 2023 without any critical/major observation

Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients

Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre

Briefs: Granules India

Granules India received approval from Brazilian Health Regulatory Agency ANVISA

Hikal receives Brazilian GMP certification and USFDA EIR for Bangalore and Panoli facilities

USFDA concludes inspection at Solara's Cuddalore facility with Zero 483 inspectional observations